J1628 Injection, guselkumab, 1 mg
Billable / valid for submission HCPCS Release 2026Q3
Short description: Inj., guselkumab, 1 mg
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Injection, guselkumab, 1 mg | yes |
Related codes in J16
- J1600 Injection, gold sodium thiomalate, up to 50 mg
- J1602 Injection, golimumab, 1 mg, for intravenous use
- J1610 Injection, glucagon hydrochloride, per 1 mg
- J1611 Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg
- J1612 Injection, glucagon (gvoke), 0.01 mg
- J1626 Injection, granisetron hydrochloride, 100 mcg
- J1627 Injection, granisetron, extended-release, 0.1 mg
- J1630 Injection, haloperidol, up to 5 mg
- J1631 Injection, haloperidol decanoate, per 50 mg
- J1632 Injection, brexanolone, 1 mg
- J1640 Injection, hemin, 1 mg
- J1642 Injection, heparin sodium, (heparin lock flush), per 10 units
- J1643 Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units
- J1644 Injection, heparin sodium, per 1000 units
- J1645 Injection, dalteparin sodium, per 2500 iu
- J1650 Injection, enoxaparin sodium, 10 mg
- J1652 Injection, fondaparinux sodium, 0.5 mg
- J1670 Injection, tetanus immune globulin, human, up to 250 units
- J1675 Injection, histrelin acetate, 10 micrograms